This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Oliver Excell
Advertisement
Oliver Excell is an implementation expert at PA Consulting.
Articles by Oliver Excell
Advertisement
Latest Updated Articles
Advertisement
Advertisement